SNDL Inc. Common Shares (SNDL)
SNDL trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 40-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1766600/000119312526102524/0001193125-26-102524-index.htm. Net income: SEC 40-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), fiscal year ended 2025-12-31. Converted from CAD at 1.4258 per USD (today's ECB or Federal Reserve reference rate).
Profile
| Field | Value |
|---|---|
| Ticker | SNDL on Nasdaq |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | Canada |
| IPO year | 2019 |
| SEC CIK | 0001766600 |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Incorporated in | AB |
| Canadian listing | CSE: SNDL |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $663.8M |
| Net income | -$11.1M |
| Operating income | -$4.5M |
| Net margin | -1.7% |
| Operating margin | -0.7% |
| Revenue growth | +2.8% |
| Cash | $176.9M |
| Total assets | $937.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.5× |
Reported in CAD; shown in US dollars.
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 40-F 2026-03-12 |
| Cash and burn | 252.2M CAD cash; operating cash flow 17.7M CAD a quarter. | Report 2025-12-31 |
| Shares outstanding | 263,359,123 (2025-12-31); 263,021,847 a year earlier; 235,194,236 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures. | Cover page 2025-12-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | CBIZ CPAs P.C., New York, New York, United States | PCAOB Form AP 2026-03-16 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | 946.4M CAD | -15.8M CAD | 70.9M CAD | 252.2M CAD | No debt tags | 946.4M CAD | 40-F 2026-03-12 |
| FY 2024 2024-12-31 | 920.4M CAD | -94.8M CAD | 54.9M CAD | 218.4M CAD | No debt tags | 920.4M CAD | 40-F 2026-03-12 |
| FY 2023 2023-12-31 | 909.0M CAD | -172.7M CAD | -16.6M CAD | 195.0M CAD | No debt tags | 909.0M CAD | 40-F 2025-03-18 |
| FY 2022 2022-12-31 | 712.2M CAD | -335.1M CAD | -6.7M CAD | 279.6M CAD | No debt tags | 712.2M CAD | 20-F/A 2024-03-21 |
| FY 2021 2021-12-31 | 56.1M CAD | -227.0M CAD | -155.8M CAD | 558.3M CAD | No debt tags | 56.1M CAD | 20-F/A 2024-03-21 |
| FY 2020 2020-12-31 | 60.9M CAD | -233.2M CAD | -57.5M CAD | 60.4M CAD | No debt tags | 60.9M CAD | 20-F/A 2024-03-21 |
| FY 2019 2019-12-31 | 63.6M CAD | -271.5M CAD | -112.7M CAD | 45.3M CAD | 177.9M CAD | 63.6M CAD | 20-F 2022-04-28 |
| FY 2018 2018-02-28 | Not filed | -13.0M CAD | -5.2M CAD | 7.7M CAD | 7.0M CAD | Needs four quarters | 20-F 2020-03-31 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in CAD.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2021-03-22 |
| Latest annual report | 40-F | 2026-03-12 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-10-27 |
Source: SEC EDGAR submissions feed, 406 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.2% |
| 1 month | +18.1% |
| 3 months | +9.6% |
| Year to date | -17.5% |
| 1 year | -19.4% |
| From 52-week high | -38.0% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TLRY | Tilray Brands Inc. Common Stock | $2.34 | -3.70% | $345.8M |
| ACB | Aurora Cannabis Inc. Common Shares | $4.61 | -6.68% | $303.1M |
| USNA | USANA Health Sciences Inc. | $13.54 | +2.27% | $250.3M |
| CGC | Canopy Growth Corporation Common Shares | $0.5460 | -2.71% | $231.2M |
| MDWD | MediWound Ltd. | $13.55 | +5.04% | $195.0M |
| OBIO | Orchestra BioMed Holdings Inc. | $7.12 | -1.79% | $560.4M |
| NAGE | Niagen Bioscience Inc. | $2.01 | -2.66% | $159.2M |
| GLAS | Glass House Brands Inc. Subordinate Voting Shares | $1.29 | +1.57% | $113.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier